[Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
Reina
J
J
Unidad de Virología, Servicio de Microbiología Clínica, Hospital Universitario Son Dureta, Palma de Mallorca. jreina@hsd.es
D000146:Acids, Carbocyclic; D019943:Amino Acid Substitution; D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D001665:Binding Sites / Q000187:drug effects; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D003517:Cyclopentanes / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics; D024882:Drug Resistance, Viral / Q000235:genetics; D006146:Guanidines / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009980:Influenza A virus / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D009981:Influenza B virus / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D007251:Influenza, Human / Q000188:drug therapy*; D051379:Mice; D015394:Molecular Structure; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000235:genetics; D009975:Orthomyxoviridae / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D053139:Oseltamivir / Q000494:pharmacology / Q000627:therapeutic use; D017354:Point Mutation; D014764:Viral Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics
D000146:Acids, Carbocyclic; D000998:Antiviral Agents; D003517:Cyclopentanes; D006146:Guanidines; D014764:Viral Proteins; D053139:Oseltamivir; D009439:Neuraminidase; C414210:peramivir